LifeMD, Inc. — Director's Dealing 2023

Jun 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-06-15

Reporting Person: Yecies Eric Harold (General Counsel & CCO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-15	Common Stock	A	150000	—	Acquired	212500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-15	Employee Stock Option (Right to Buy)	$7.55	D	200000	Disposed		Common Stock (200000)	Direct

Footnotes

F1: The options are being cancelled in exchange for 150,000 restricted shares with 12,500 vesting on June 15, 2023, 37,500 shares on November 20, 2023 and 100,000 shares on January 1, 2024 and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following November 20, 2020.